Trinity Biotech - TRIB Stock Forecast, Price & News

Trinity Biotech's stock was trading at $0.99 on January 1st, 2023. Since then, TRIB stock has increased by 8.1% and is now trading at $1.07.
View the best growth stocks for 2023 here.

Trinity Biotech saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 60,600 shares, a decline of 19.8% from the December 31st total of 75,600 shares. Based on an average daily trading volume, of 33,600 shares, the days-to-cover ratio is currently 1.8 days.
View Trinity Biotech's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, April 10th 2023.
View our TRIB earnings forecast.

Trinity Biotech plc (NASDAQ:TRIB) released its quarterly earnings data on Thursday, December, 15th. The company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.14. The company had revenue of $19.50 million for the quarter, compared to analysts' expectations of $19.50 million. Trinity Biotech had a negative net margin of 42.21% and a negative trailing twelve-month return on equity of 419.23%.

Trinity Biotech updated its third quarter 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $19.00 million-$20.00 million.

20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM).

Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB."

Trinity Biotech's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Hunter Associates Investment Management LLC (4.79%) and Concourse Financial Group Securities Inc. (0.00%).

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TRIB stock can currently be purchased for approximately $1.07.

Trinity Biotech (NASDAQ:TRIB) has a market capitalization of $40.78 million and generates $92.96 million in revenue each year. The company earns $880,000.00 in net income (profit) each year or ($1.09) on an earnings per share basis.

The company employs 543 workers across the globe.

Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The official website for the company is www.trinitybiotech.com. The company can be reached via phone at (531) 276-9800, via email at kevin.tansley@trinitybiotech.com, or via fax at 353-1276-9888.